Administration of follitropin alfa and lutropin alfa combined in a single injection: A feasibility assessment

Reproductive Biology and Endocrinology

Volumn 7, Issue , 2009, Pages

  Agostinetto, Rita ^a  

^a Merck Serono SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; LUTROPIN ALFA; PERGOVERIS; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT FOLLITROPIN PLUS RECOMBINANT LUTEINIZING HORMONE; RECOMBINANT LUTEINIZING HORMONE; UNCLASSIFIED DRUG; FOLLITROPIN; LUTEINIZING HORMONE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG MIXTURE; FEASIBILITY STUDY; FEMALE; FEMALE INFERTILITY; IN VIVO STUDY; LYOPHILISATE; MALE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PROTEIN CONTENT; RAT; REPRODUCTIVE PROCEDURES; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPRAGUE DAWLEY RAT; ANIMAL; DRUG COMBINATION; INJECTION; METHODOLOGY; POWDER;

RATTUS;

ANIMALS; BIOLOGICAL ASSAY; DRUG COMBINATIONS; DRUG COMPOUNDING; FEASIBILITY STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; INFERTILITY, FEMALE; INJECTIONS; LUTEINIZING HORMONE; POWDERS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 66749138958     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-7-48     Document Type: Article

References (20)

1. Hillier SG Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis Hum Reprod 1994, 9:188-191. 8027271
2. Somkuti SG Schertz JC Moore M Ferrande L Kelly E Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women Curr Med Res Opin 2006, 22:1981-1996. 10.1185/030079906X132604 17022858
3. Porter R Kissel C Saunders H Keck C Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens Curr Med Res Opin 2008, 24:727-735. 10.1185/030079908X273291 18230195
4. Pergoveris SPC http://emc.medicines.org.uk/emc/assets/c/html/ DisplayDoc.asp?DocumentID=20132
5. Steelman SL Pohley FM Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin Endocrinology 1953, 53:604-616. 13116950
6. Storring PL Gaines Das RE The fourth International Standard for Human Urinary FSH and LH: Specificities of LH seminal vesicle weight gain assays in the collaborative study differ between laboratories J Endocrinol 2001, 171:119-129. 10.1677/joe.0.1710119 11572796
7. Olivius C Friden B Borg G Bergh C Why do couples discontinue in vitro fertilization treatment? A cohort study Fertil Steril 2004, 81:258-261. 10.1016/j.fertnstert.2003.06.029 14967352
8. le Cotonnec JY Loumaye E Porchet HC Beltrami V Munafo A Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone Fertil Steril 1998, 69:201-209. 10.1016/S0015-0282(97)00503-7 9496329
9. le Contonnec JY Porchet HC Beltrami V Khan A Toon S Rowland M Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics Fertil Steril 1994, 61:679-686. 8150110
10. le Cotonnec JY Porchet HC Beltrami V Khan A Toon S Rowland M Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH Fertil Steril 1994, 61:669-678. 8150109
11. le Cotonnec JY Porchet HC Beltrami V Munafo A Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay Fertil Steril 1998, 69:195-200. 10.1016/ S0015-0282(97)00502-5 9496328
12. le Cotonnec JY Porchet HC Beltrami V Munafo A Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone Fertil Steril 1998, 69:189-194. 10.1016/S0015-0282(97)00501-3 9496327
13. Porchet HC le Cotonnec JY Loumaye E Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration Fertil Steril 1994, 61:687-695. 8150111
14. Alper M Meyer R Dekkers C Ezcurra D Schertz J Kelly E Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: A comparative trial in Sprague-Dawley rats Reprod Biol Endocrinol 2008, 6:31. 2494996 18647398 10.1186/1477-7827-6-31
15. Marrs R Meldrum D Muasher S Schoolcraft W Werlin L Kelly E Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment Reprod Biomed Online 2004, 8:175-182. 14989794
16. Scobey MJ Raike E Marshall DC Mixed protocols: Multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe Reprod Biol Endocrinol 2005, 3:61. 1298331 16280072 10.1186/1477-7827-3-61
17. Gardner D Weissman A Howles C Shoham Z Eds Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives London: Taylor and Francis 2004.
18. Driebergen R Baer G Quantification of follicle stimulating hormone (follitropin alfa): Is in vivo bioassay still relevant in the recombinant age? Curr Med Res Opin 2003, 19:41-46. 10.1185/ 030079902125001344 12661779
19. Lunenfeld B Historical perspectives in gonadotrophin therapy Hum Reprod Update 2004, 10:453-467. 10.1093/humupd/dmh044 15388674
20. United States Pharmacopeia and National Formulary (USP 28-NF) Rockville, MD: United States Pharmacopeia Convention 2004:2274-2286.